Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization

Comparative genomic hybridization (CGH) was used to detect and map the regions of gain, high‐level amplification, and loss of DNA sequences in 14 liposarcomas. Thirteen tumors showed DNA sequence copy number changes of one or more genomic regions (mean, six aberrations/tumor; range, 0–17). These aberrations were observed in almost every chromosome but some chromosomal regions were affected more often than others. DNA sequence gains were more frequent than losses. The most common gain was seen at 12q14‐21 (50% of tumors). Other frequent gains (29%) were of Iq21‐24, 8cen‐q21.2, 19q, and 20q. High‐level amplification was observed in six (43%) tumors and included as minimal common segments bands 12q15, Iq22, and Iq24. In five (36%) tumors, sequences at Iq21‐24 and Iq32 were found to be gained simultaneously with 12q14‐21, which means that in 71% of the tumors with gain at 12q, an increase of DNA sequence copy number at Iq was also observed. The most common losses of DNA sequences (21%) occurred from regions 9p21‐pter and 13q21‐qter. Most of the aforementioned regions have not previously been reported to be altered in liposarcomas. The detection of a novel recurring amplicon at Iq21‐24 with high‐level amplification at Iq22 and frequent simultaneous DNA sequence gain at 12q14‐21 (high‐level amplification at 12q15) suggests that genes linked to both these regions may play a significant role in the development and progression of liposarcomas. Genes Chromosom Cancer 15:89–94 (1996). © 1996 Wiley‐Liss, Inc.

[1]  S. Knuutila,et al.  Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. , 1995, Cancer research.

[2]  S. Devries,et al.  Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization , 1995, Genes, chromosomes & cancer.

[3]  A. Peier,et al.  Deletion 6q in three cases of mixed-type liposarcoma in addition to t(12;16)(q13;p11) , 1995, Cancer genetics and cytogenetics.

[4]  L. Donner Cytogenetics of tumors of soft tissue and bone. Implication for pathology. , 1994, Cancer genetics and cytogenetics.

[5]  O. Myklebost,et al.  The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. , 1994, Cancer genetics and cytogenetics.

[6]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[7]  J Piper,et al.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.

[8]  M. Ladanyi,et al.  Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. , 1994, The American journal of pathology.

[9]  F. Collin,et al.  Complex composition and co‐amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well‐differentiated liposarcoma , 1994, Genes, chromosomes & cancer.

[10]  O. Myklebost,et al.  Comparative genomic hybridization as a tool to define two distinct chromosome 12‐derived amplification units in well‐differentiated liposarcomas , 1994, Genes, chromosomes & cancer.

[11]  Mef Nilbert,et al.  MDM2 gene amplification correlates with ring chromosomes in soft tissue tumors , 1994 .

[12]  A. Jauch,et al.  Copyright ©) American Society for Investigative Pathology Comparative Genomic Hybridization of Human Malignant Gliomas Reveals Multiple Amplification Sites and Nonrandom Chromosomal Gains and Losses , 2022 .

[13]  P. Meltzer,et al.  Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[14]  A. Look,et al.  Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. , 1993, Cancer research.

[15]  P. Cin,et al.  Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. , 1993, Cancer genetics and cytogenetics.

[16]  N. Mandahl,et al.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma , 1993, Nature.

[17]  R. Larson,et al.  Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma , 1993, Nature Genetics.

[18]  P. Meltzer,et al.  p53 Mutation and MDM2 amplification in human soft tissue sarcomas. , 1993, Cancer research.

[19]  F. Collin,et al.  Chromosome 12 origin in rings and giant markers in well-differentiated liposarcoma. , 1993, Cancer genetics and cytogenetics.

[20]  Y. Kaneko,et al.  Chromosome abnormalities in liposarcomas. , 1992, Cancer genetics and cytogenetics.

[21]  F. Mitelman,et al.  Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11) , 1992, Genes, chromosomes & cancer.

[22]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[23]  P. Meltzer,et al.  SAS amplification in soft tissue sarcomas. , 1992, Cancer research.

[24]  P. Cin,et al.  Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas. , 1986, Cancer genetics and cytogenetics.

[25]  F. Enzinger,et al.  Soft tissue tumors , 1988 .